389 resultados para Monge


Relevância:

10.00% 10.00%

Publicador:

Resumo:

Diese Arbeit befasst sich mit Eduard Study (1862-1930), einem der deutschen Geometer um die Jahrhundertwende, der seine Zeit zum Einen durch seine Kontakte zu Klein, Hilbert, Engel, Lie, Gordan, Halphen, Zeuthen, Einstein, Hausdorff und Weyl geprägt hat, zum Anderen in ihr aber auch für seine beißenden und stilistisch ausgefeilten Kritiken ebenso berühmt wie berüchtigt war. Da sich Study mit einer Vielzahl mathematischer Themen beschäftigt hat, führen wir zunächst in die von ihm bearbeiteten Gebiete der Geometrie des 19. Jahrhunderts ein (analytische und synthetische Geometrie im Sinne von Monge, Poncelet, Plücker und Reye, Invariantentheorie Clebsch-Gordan'scher Prägung, abzählende Geometrie von Chasles und Halphen, die Werke Lie's und Grassmann’s, Liniengeometrie sowie Axiomatik und Grundlagenkrise). In seiner darauf folgenden Biographie finden sich als zentrale Stellen seine Habilitation bei Klein über die Chasles’sche Vermutung, sein Streit mit Zeuthen darüber als eine der Debatten der Mathematischen Annalen (aus der er historisch zwar nicht, mathematisch aber tatsächlich als Gewinner hätte herausgehen müssen, wie wir an der Lösung des Problems durch van der Waerden sehen werden) und seine Auseinandersetzungen als etablierter Bonner Professor mit Engel über Lie, Weyl über Invariantentheorie, zahlreichen philosophischen Richtungen über das Raumproblem, Pasch’s Axiomatik, Hilbert’s Formalismus sowie Brouwer’s und Weyl’s Intuitionismus.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

OBJECTIVES The aim of this study was to evaluate right ventricular (RV) and left ventricular function and pulmonary circulation in chronic mountain sickness (CMS) patients with rest and stress echocardiography compared with healthy high-altitude (HA) dwellers. BACKGROUND CMS or Monge's disease is defined by excessive erythrocytosis (hemoglobin >21 g/dl in males, 19 g/dl in females) and severe hypoxemia. In some cases, a moderate or severe increase in pulmonary pressure is present, suggesting a similar pathogenesis of pulmonary hypertension. METHODS In La Paz (Bolivia, 3,600 m sea level), 46 CMS patients and 40 HA dwellers of similar age were evaluated at rest and during semisupine bicycle exercise. Pulmonary artery pressure (PAP), pulmonary vascular resistance, and cardiac function were estimated by Doppler echocardiography. RESULTS Compared with HA dwellers, CMS patients showed RV dilation at rest (RV mid diameter: 36 ± 5 mm vs. 32 ± 4 mm, CMS vs. HA, p = 0.001) and reduced RV fractional area change both at rest (35 ± 9% vs. 43 ± 9%, p = 0.002) and during exercise (36 ± 9% vs. 43 ± 8%, CMS vs. HA, p = 0.005). The RV systolic longitudinal function (RV-S') decreased in CMS patients, whereas it increased in the control patients (p < 0.0001) at peak stress. The RV end-systolic pressure-area relationship, a load independent surrogate of RV contractility, was similar in CMS patients and HA dwellers with a significant increase in systolic PAP and pulmonary vascular resistance in CMS patients (systolic PAP: 50 ± 12 mm Hg vs. 38 ± 8 mm Hg, CMS vs. HA, p < 0.0001; pulmonary vascular resistance: 2.9 ± 1 mm Hg/min/l vs. 2.2 ± 1 mm Hg/min/l, p = 0.03). Both groups showed comparable systolic and diastolic left ventricular function both at rest and during stress. CONCLUSIONS Comparable RV contractile reserve in CMS and HA suggests that the lower resting values of RV function in CMS may represent a physiological adaptation to chronic hypoxic conditions rather than impaired RV function. (Chronic Mountain Sickness, Systemic Vascular Function [CMS]; NCT01182792).

Relevância:

10.00% 10.00%

Publicador:

Resumo:

BACKGROUND High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-term comparisons between settings have been limited by poor ascertainment of mortality in high burden African settings. This study aimed to compare mortality up to four years on ART between South Africa, Europe, and North America. METHODS AND FINDINGS Data from four South African cohorts in which patients lost to follow-up (LTF) could be linked to the national population register to determine vital status were combined with data from Europe and North America. Cumulative mortality, crude and adjusted (for characteristics at ART initiation) mortality rate ratios (relative to South Africa), and predicted mortality rates were described by region at 0-3, 3-6, 6-12, 12-24, and 24-48 months on ART for the period 2001-2010. Of the adults included (30,467 [South Africa], 29,727 [Europe], and 7,160 [North America]), 20,306 (67%), 9,961 (34%), and 824 (12%) were women. Patients began treatment with markedly more advanced disease in South Africa (median CD4 count 102, 213, and 172 cells/µl in South Africa, Europe, and North America, respectively). High early mortality after starting ART in South Africa occurred mainly in patients starting ART with CD4 count <50 cells/µl. Cumulative mortality at 4 years was 16.6%, 4.7%, and 15.3% in South Africa, Europe, and North America, respectively. Mortality was initially much lower in Europe and North America than South Africa, but the differences were reduced or reversed (North America) at longer durations on ART (adjusted rate ratios 0.46, 95% CI 0.37-0.58, and 1.62, 95% CI 1.27-2.05 between 24 and 48 months on ART comparing Europe and North America to South Africa). While bias due to under-ascertainment of mortality was minimised through death registry linkage, residual bias could still be present due to differing approaches to and frequency of linkage. CONCLUSIONS After accounting for under-ascertainment of mortality, with increasing duration on ART, the mortality rate on HIV treatment in South Africa declines to levels comparable to or below those described in participating North American cohorts, while substantially narrowing the differential with the European cohorts. Please see later in the article for the Editors' Summary.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

BACKGROUND Recommendations have differed nationally and internationally with respect to the best time to start antiretroviral therapy (ART). We compared effectiveness of three strategies for initiation of ART in high-income countries for HIV-positive individuals who do not have AIDS: immediate initiation, initiation at a CD4 count less than 500 cells per μL, and initiation at a CD4 count less than 350 cells per μL. METHODS We used data from the HIV-CAUSAL Collaboration of cohort studies in Europe and the USA. We included 55 826 individuals aged 18 years or older who were diagnosed with HIV-1 infection between January, 2000, and September, 2013, had not started ART, did not have AIDS, and had CD4 count and HIV-RNA viral load measurements within 6 months of HIV diagnosis. We estimated relative risks of death and of death or AIDS-defining illness, mean survival time, the proportion of individuals in need of ART, and the proportion of individuals with HIV-RNA viral load less than 50 copies per mL, as would have been recorded under each ART initiation strategy after 7 years of HIV diagnosis. We used the parametric g-formula to adjust for baseline and time-varying confounders. FINDINGS Median CD4 count at diagnosis of HIV infection was 376 cells per μL (IQR 222-551). Compared with immediate initiation, the estimated relative risk of death was 1·02 (95% CI 1·01-1·02) when ART was started at a CD4 count less than 500 cells per μL, and 1·06 (1·04-1·08) with initiation at a CD4 count less than 350 cells per μL. Corresponding estimates for death or AIDS-defining illness were 1·06 (1·06-1·07) and 1·20 (1·17-1·23), respectively. Compared with immediate initiation, the mean survival time at 7 years with a strategy of initiation at a CD4 count less than 500 cells per μL was 2 days shorter (95% CI 1-2) and at a CD4 count less than 350 cells per μL was 5 days shorter (4-6). 7 years after diagnosis of HIV, 100%, 98·7% (95% CI 98·6-98·7), and 92·6% (92·2-92·9) of individuals would have been in need of ART with immediate initiation, initiation at a CD4 count less than 500 cells per μL, and initiation at a CD4 count less than 350 cells per μL, respectively. Corresponding proportions of individuals with HIV-RNA viral load less than 50 copies per mL at 7 years were 87·3% (87·3-88·6), 87·4% (87·4-88·6), and 83·8% (83·6-84·9). INTERPRETATION The benefits of immediate initiation of ART, such as prolonged survival and AIDS-free survival and increased virological suppression, were small in this high-income setting with relatively low CD4 count at HIV diagnosis. The estimated beneficial effect on AIDS is less than in recently reported randomised trials. Increasing rates of HIV testing might be as important as a policy of early initiation of ART. FUNDING National Institutes of Health.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

El presente trabajo se realiza en relación a la problemática de los adolescentes, la violencia y el delito en nuestra sociedad, específicamente interesa abordar una problemática que involucra a adolescentes infractores de la ley insertos en el Programa Unidad de Medidas Alternativas (en adelante U.M.A.) del Valle de Uco de Mendoza. Lo que lleva a trabajar en este tema es poder analizar la problemática del adolescente desde un enfoque distinto, interpretativo e integral. La participación de los jóvenes en hechos delictivos se plantea hoy como un problema de gran connotación social y son muchos los debates que giran en torno a dicha problemática. Los hechos de inseguridad en donde los protagonistas son los adolescentes ocupan un lugar importante en la agenda política y de las políticas públicas. Sin embargo, la vigencia de discursos positivistas y represivos – de corte retributivos, del castigo por el castigo mismo- se ponen a la orden del día, constituyéndose en políticas de estado que poco tienen que ver con solucionar el problema de raíz, menos aún en los contextos rurales. Por otra parte, la motivación a dicho trabajo, se contextualiza en la necesidad de realizar un aporte teórico metodológico a la temática, desarrollando y describiendo a los adolescentes en conflicto con la ley como “un fenómeno social", pertenecientes a familias transgresoras, tradicionales y vulnerables, expuestas a factores de riesgos como inicio temprano en el consumo de drogas, vivir en lugares conflictivos, vulnerabilidad socioeconómica entre otras.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Protease inhibitors from plants have been involved in defence mechanisms against pests and pathogens. Phytocystatins and trypsin/α-amylase inhibitors are two of the best characterized protease inhibitor families in plants. In barley, thirteen cystatins (HvCPI-1 to 13) and the BTI-CMe trypsin inhibitor have been previously studied. Their capacity to inhibit pest digestive proteases, and the negative in vivo effect caused by plants expressing these inhibitors on pests support the defence function of these proteins. Barley cystatins are also able to inhibit in vitro fungal growth. However, the antifungal effect of these inhibitors in vivo had not been previously tested. Moreover, their in vitro and in vivo effect on plant pathogenous bacteria is still unknown. In order to obtain new insights on this feature, in vitro assays were made against different bacterial and fungal pathogens of plants using the trypsin inhibitor BTI-CMe and the thirteen barley cystatins. Most barley cystatins and the BTI-CMe inhibitor were able to inhibit mycelial growth but no bacterial growth. Transgenic Arabidopsis plants independently expressing the BTI-CMe inhibitor and the cystatin HvCPI-6 were tested against the same bacterial and fungal pathogens. Neither the HvCPI-6 expressing transgenic plants nor the BTI-CMe ones were more resistant to plant pathogen fungi and bacteria than control Arabidopsis plants. The differences observed between the in vitro and in planta assays against phytopathogenic fungi are discussed